Antidiabetic Tablets Manufacturer India

What We Manufacture

Our Antidiabetics tablet range

India is the diabetes capital of the world with 101 million diabetic patients. Our antidiabetic tablet range covers the complete treatment pathway — from first-line Metformin through to newer agents — manufactured under WHO-GMP conditions with the documentation required for government programmes and export registration.

Biguanides — First-Line Therapy

Metformin remains the cornerstone of Type 2 diabetes management globally — on the WHO Essential Medicines List.

Metformin 500mg · 850mg · 1000mg IR Tablet
Metformin 500mg · 750mg · 1000mg ER (Extended-Release) Tablet
Metformin + Glimepiride combination tablet
Metformin + Sitagliptin combination tablet

Sulfonylureas

Insulin secretagogues for Type 2 diabetes management as monotherapy or in combination with Metformin.

Glimepiride 1mg · 2mg · 3mg · 4mg Tablet
Glipizide 2.5mg · 5mg · 10mg Tablet
Glibenclamide 2.5mg · 5mg Tablet

DPP-4 Inhibitors

Newer oral antidiabetics with lower hypoglycaemia risk — increasingly prescribed as second-line therapy.

Sitagliptin 25mg · 50mg · 100mg Tablet
Vildagliptin 50mg Tablet
Teneligliptin 20mg Tablet

SGLT2 Inhibitors — Newer Agents

Sodium-glucose cotransporter-2 inhibitors providing glucose lowering with cardiovascular and renal protective benefits.

Dapagliflozin 5mg · 10mg Tablet
Empagliflozin 10mg · 25mg Tablet
Canagliflozin 100mg · 300mg Tablet

Available Tablet Types

Standard tablets — compressed, film-coated
Enteric-coated tablets — delayed release
Extended-release tablets — controlled delivery
Dispersible tablets — dissolves in water
Alu-Alu cold form blister · Alu-PVC blister · Strip packing

Enquire Now

Why 9M India

Antidiabetic tablet manufacturing — precision formulation for a chronic disease population

WHO-GMP certified solid dosage manufacturing

Antidiabetic tablets, particularly Metformin ER and combination tablets, require precise dissolution profiles and consistent drug release characteristics. 9M India's WHO-GMP facility uses validated granulation and compression processes with in-process dissolution testing to ensure every batch delivers the specified release profile — critical for chronic disease management.
In-house QC — every batch tested before dispatch

Dissolution testing · Disintegration · Hardness · Friability · Assay (HPLC) · Content uniformity · Related substances · Microbiological limits — all tested in our in-house analytical laboratory. Certificate of Analysis issued from our own facility.
Documentation ready for government tenders and export

Manufacturing Licence · DCGI product approvals · WHO-GMP Certificate · COA · COC · Stability data (ICH aligned) — pre-prepared and available within 24 hours for tender submission, export registration or CDMO due diligence.

Who We Supply

Who sources antidiabetic tablets from 9M India

Government & institutional buyers

Government diabetes management programmes, NHM, CGHS, Ayushman Bharat pharmacies — antidiabetic tablets are among the fastest-growing categories in government pharmaceutical procurement as India's diabetes burden grows.
Domestic pharma brands (3PM/Private Label)

Domestic pharma brands manufacturing antidiabetic tablets through 9M India — complete private label capability from Metformin IR through newer agents like Dapagliflozin.
International export buyers

Middle Eastern, South-East Asian and African export buyers — diabetes prevalence is rising rapidly across all export markets, driving sustained antidiabetic tablet demand growth.